Lyophilized Injectable Market Scope and Analysis Report by 2028
Lyophilized Injectable Market Report Scope
Report Attribute | Details |
---|---|
Market size in 2021 | US$ 2.72 Billion |
Market Size by 2028 | US$ 4 Billion |
Global CAGR (2021 - 2028) | 5.8% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By Type of Packaging
|
Regions and Countries Covered | North America
|
Market leaders and key company profiles |
Global Lyophilized Injectable Market – by Geography
Geographically, the global lyophilized injectable market is segmented into North America (the US, Canada, and Mexico), Europe (Germany, the UK, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Australia, and the Rest of APAC), Middle East & Africa (South Africa, Saudi Arabia, the UAE, and the Rest of MEA), and South and Central America (Brazil, Argentina, and the Rest of South & Central America).
Company Profiles
- Baxter
- Nipro
- Curia Global, Inc.
- Recipharm AB
- Vetter Pharma
- Jubilant HollisterStier LLC (Jubilant Pharma Limited)
- Aristopharma Ltd.
- CordenPharma International
- Credence MedSystems, Inc.
- S. G. Biopharm Pvt. Ltd